Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
Clinical trial NCT01336023 · COMPLETED
Trial details
- NCT number
- NCT01336023
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-23
- Primary completion
- 2012-05-24
- Enrollment
- 1663
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.